在医疗领域，公司已开发完成医用防辐射服、医用散射射线防护毯，医用防辐射服轻量化特性可以降低 医护人员工作过程中的负重，医用散射射线防护毯可有效减少手术中辐射剂量，增加成像清晰度，产品 填补了国内空白。 公司表示，本次投资，是公司立足长远业务发展战略作出的重要决策。将充分依托项目所在地的优质资 源禀赋，通过此次投资进一步扩大产能规模，持续优化产业结构布局，从而深度推进在辐射防护材料领 域的市场拓展进程，增强公司盈利能力。 据协议，公司拟在岳林街道斯张村工业8-2号地块投建年产3万套医用射线无铅防护系列产品及新材料项 目，建设内容包括医疗和核工业防辐射材料生产用房和办公楼等，计划总投资1.5亿元，其中固定资产 投资不低于1.05亿元。 资料显示，公司研制的高能射线无铅防护材料是能够屏蔽X射线和γ射线等高能量射线的高分子复合材 料，兼具轻质、柔软、无铅环保特性，主要应用于医疗、安检、食品检测、核工业等领域，可全面替代 传统的含铅材料。 核校：王博 ...

Group 1: Market Performance and Product Advantages - The company's radiation protection materials achieved a doubling growth in 2024, driven by technological leadership, superior product performance, cost advantages, and eco-friendly characteristics [1] - The introduction of lead-free radiation protection materials has opened up the market, supported by core patents and innovative results that establish a technological barrier [2] - The flexible lead-free protection materials match the cost of traditional lead-containing products while eliminating harmful substances, addressing global environmental regulations and the demand for lead-free solutions [2] Group 2: Market Penetration Strategies - The company has leveraged over a decade of technological accumulation to develop high-energy radiation lead-free protection materials, which effectively shield X-rays and γ-rays [2] - Targeting sectors such as medical, security, and food safety, the company has introduced products like medical scatter radiation protection blankets and adapted protective materials for food safety testing [2] - The company has successfully expanded its customer base through participation in exhibitions and academic conferences, collaborating with medical institutions and manufacturers [2] Group 3: Research and Development Breakthroughs - The company focuses on a micro-nano powder technology platform, achieving significant breakthroughs in various projects, including infrared absorption materials and transparent radiation protection materials [3] - The development of metal electronic powders and special ultra-fine metal powders is underway, with products entering customer validation stages [3] - The company plans to continue increasing R&D investment, with a projected R&D expenditure of 88.6 million yuan in 2024, representing a 69% increase and accounting for 9.6% of revenue [4] Group 4: Future Strategic Planning - The company aims to strengthen its core competencies in functional materials through sustained R&D investment, enhancing product performance and value [4] - The long-term investment strategy is designed to accelerate product upgrades and establish differentiated competitive advantages in the market [4] - The company anticipates achieving a revenue of 850.996 million yuan in 2024, reflecting a year-on-year growth of 14.94% [4]